China National Accord Medicines Corporation Ltd.

SZSE:000028.SZ

28.31 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991
Revenue 75,477.48573,443.13768,357.8159,649.45552,045.76443,122.38641,263.62941,248.42925,993.13923,954.33121,199.46618,011.75915,130.33913,064.42810,949.9378,360.356,878.3055,667.6121,635.5691,576.0851,780.8741,869.9381,668.675107.89990.18788.43884.618151.69161.202128.896119.46584.52162.385
Cost of Revenue 66,471.13164,516.92660,339.29852,591.76746,292.40938,024.10936,819.55336,648.23723,972.04322,002.62919,436.08216,408.7213,796.01411,925.65610,021.297,627.8116,171.2045,085.9771,262.4231,202.8311,349.1881,456.5281,206.3469.44255.25762.55857.37689.114103.53274.33855.53142.260
Gross Profit 9,006.3538,926.2118,018.5127,057.6885,753.3555,098.2774,444.0764,600.1922,021.0971,951.7021,763.3851,603.0391,334.3241,138.773928.647732.539707.101581.634373.145373.254431.686413.41462.33538.45734.9325.8827.24262.57657.66954.55863.93442.26162.385
Gross Profit Ratio 0.1190.1220.1170.1180.1110.1180.1080.1120.0780.0810.0830.0890.0880.0870.0850.0880.1030.1030.2280.2370.2420.2210.2770.3560.3870.2930.3220.4130.3580.4230.5350.51
Reseach & Development Expenses 26.8219.0677.741000043.73273.1581.21679.4379.36363.51752.8310000000000000000000
General & Administrative Expenses 215.287197.702183.416190.618159.322145.394133.847169.94277.82592.52782.75570.1481.1366.458245.892204.916188.973180.857105.63469.84777.94799.35296.21440.91329.39238.17732.88227.66822.98817.97212.6466.6290
Selling & Marketing Expenses 2,590.2695,272.8064,752.8633,951.5123,067.8992,772.0292,309.1932,205.783533.791522.383486.39448.595429.901430.589384.236298.327331.527302.041248.325294.613334.484309.457326.13219.2718.22220.85321.344.5866.6217.9423.8423.330
SG&A 6,480.0015,470.5094,936.2794,142.1293,227.2212,917.4242,443.042,375.726611.616614.91569.146518.735511.031497.047630.128503.242520.5482.898353.958364.459412.431408.809422.34760.18347.61559.0354.22332.25429.60925.91416.4889.960
Other Expenses 6.5071,034.166928.269891.451763.0787.9512.13853.42555.16748.33813.73640.95620.6517.4619.38419.69122.3637.24623.0422.819.23416.72228.25122.9744.3549.6531.11412.2753.03112.5712.261-1.1190
Operating Expenses 6,584.6346,513.7415,864.5485,033.5813,990.2993,638.6823,137.6283,182.1961,043.5181,043.442954.447887.003818.185751.382645.722514.375532.745491.12356.121366.923415.067411.821425.02760.24547.70459.14554.27732.29630.0426.13625.62115.7320
Operating Income 2,467.4252,306.0691,952.4112,163.8411,835.5471,670.9791,463.8911,548.159906.593781.487645.008571.465387.065322.899251.941184.299169.328101.42241.6921.4284.758-7.60424.666-16.93533.44510.254-28.01637.82525.77234.24638.34826.67362.385
Operating Income Ratio 0.0330.0310.0290.0360.0350.0390.0350.0380.0350.0330.030.0320.0260.0250.0230.0220.0250.0180.0250.0140.003-0.0040.015-0.1570.3710.116-0.3310.2490.160.2660.3210.3161
Total Other Income Expenses Net 5.80113.47322.442-6.60521.1117.9512.13842.924-94.849-2.62-112.908-91.525-117.185-65.58493.96721.7233.25442.2544.2296.9239.6826.9347.955-5.888-1.373-0.60310.4531.8988.0970-1.995-45.744
Income Before Tax 2,473.2272,311.071,974.8532,157.2361,856.6581,678.9291,466.0291,600.257961.308829.283659.102603.317409.282339.812260.787203.498191.051104.67741.6225.65712.2332.07846.12-2.97627.5578.987-29.90248.27827.66942.34338.34824.67716.641
Income Before Tax Ratio 0.0330.0310.0290.0360.0360.0390.0360.0390.0370.0350.0310.0330.0270.0260.0240.0240.0280.0180.0250.0160.0070.0010.028-0.0280.3060.102-0.3530.3180.1720.3290.3210.2920.267
Income Tax Expense 514.739539.332447.211435.94372.439330.498309.29318.377173.96159.442124.883119.63581.46675.58862.52741.04452.33329.96.0966.9445.4728.01211.5090.6031.933-56.052-4.1528.2574.5766.3215.6843.9942.683
Net Income 1,599.2561,486.7081,336.4281,401.8931,271.2891,210.7421,057.7921,186.602761.312652.497520.488475.792330.307261.117192.714154.807124.91472.55535.76527.25415.1914.92336.517-1.78520.58514.119-29.7340.54223.33336.02232.66420.68313.958
Net Income Ratio 0.0210.020.020.0240.0240.0280.0260.0290.0290.0270.0250.0260.0220.020.0180.0190.0180.0130.0220.0170.0090.0030.022-0.0170.2280.16-0.3510.2670.1450.2790.2730.2450.224
EPS 2.872.672.42.522.282.181.92.151.681.461.391.270.880.70.520.420.330.210.0960.0730.0410.0130.056-0.0060.0550.015-0.10.110.0620.0960.0870.0720.049
EPS Diluted 2.872.672.42.522.282.181.92.151.681.461.391.270.880.70.520.420.330.210.0960.0730.0410.0130.056-0.0060.0550.015-0.10.110.0620.0960.0870.0720.049
EBITDA 4,032.043,762.2963,401.4973,295.1332,757.2291,801.2171,556.041,899.851,224.5451,087.347940.443821.187607.356478.866361.28303.485253.783115.41861.23253.57444.33534.23564.37610.5374.671-15.749-30.03530.2827.62928.422-25.62126.52962.385
EBITDA Ratio 0.0530.0560.0560.060.0590.0460.0410.0460.0470.0480.0460.0490.0430.0390.0350.0350.0380.0280.0370.0340.0250.0180.0470.1530.052-0.214-0.3190.20.1710.221-0.2140.3141